EDESA BIOTECH, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
EDESA BIOTECH, INC. (EDSA) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 9-month period ending 2024-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2025-08-08
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2023-12-31 was 0.00%.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2022-12-31 was 0.00%.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2021-12-31 was 0.00%.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2020-12-31 was 0.00%.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2021 was 0.00%.
- EDESA BIOTECH, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2020 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|
| 2024-06-30 | 0.00% 10-Q · filed 2025-08-08 | |||
| 2024-03-31 | 0.00% 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | 0.00% 10-Q · filed 2025-02-14 | |||
| 2023-09-30 | 0.00% 10-K · filed 2023-12-15 | |||
| 2023-06-30 | 0.00% 10-Q · filed 2024-08-09 | |||
| 2023-03-31 | 0.00% 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | 0.00% 10-Q · filed 2024-02-09 | |||
| 2022-09-30 | 0.00% 10-K · filed 2023-12-15 | |||
| 2022-06-30 | 0.00% 10-Q · filed 2023-08-09 | |||
| 2022-03-31 | 0.00% 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | 0.00% 10-Q · filed 2022-02-14 | |||
| 2021-09-30 | 0.00% 10-K · filed 2022-12-16 | |||
| 2021-06-30 | 0.00% 10-Q · filed 2022-08-12 | |||
| 2021-03-31 | 0.00% 10-Q · filed 2022-05-13 | |||
| 2020-12-31 | 0.00% 10-Q · filed 2021-02-16 | |||
| 2020-09-30 | 0.00% 10-K · filed 2021-12-28 | |||
| 2020-06-30 | 0.00% 10-Q · filed 2021-08-13 | |||
| 2020-03-31 | 0.00% 10-Q · filed 2021-05-14 | |||
| 2019-09-30 | 0.00% 10-K · filed 2020-12-07 | |||
| 2019-06-30 | 0.00% 10-Q · filed 2020-08-12 | |||
| 2019-03-31 | 0.00% 10-Q · filed 2020-05-15 | |||
| 2018-12-31 | 0.00% 10-Q · filed 2020-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |